Latest News and Events
Filter by
Selections
June 29, 2018
Arrowhead Presents New Clinical Data on ARO-AAT at Alpha-1 National Education Conference
Read MoreJune 27, 2018
Arrowhead Receives Positive EMA Opinion on Orphan Designation for ARO-AAT for Treatment of Congenital Alpha-1 Antitrypsin Deficiency
Read MoreJune 18, 2018
Arrowhead Completes Enrollment in Phase 1 Study of ARO-AAT for Treatment of Alpha-1 Liver Disease
Read MoreJune 8, 2018
Arrowhead Pharmaceuticals Reports Inducement Grants under NASDAQ Marketplace Rule 5635(c)(4)
Read MoreMay 30, 2018